A leading provider of Closed System Transfer Devices- Equashield at  the ISOPP symposium to be held in Shanghai this year will be for the first time leading on using robotics for cytotoxic drug handling.

Equashield, a leading provider of Closed System Transfer Devices (CSTDs) for hazardous drugs, announced today that it will be leading a symposium exploring the use of robotics in cytotoxic drug handling at the International Symposium on Oncology Pharmacy Practice (ISOPP). The symposium will introduce the Equashield Pro, the first drug compounding robot utilizing Equashield's proprietary CSTD technology. It will also discuss the role that the Equashield Pro will play in increasing pharmacy throughput while simultaneously keeping pharmacists safe.

The symposium will feature presentations from leading industry experts: Yaakov Cass, District Pharmacist Emeritus for the Israeli Ministry of Health, on Robotics in Cytotoxics: The Final Frontier and Dr. Salim Hadad, Director of the Pharmaceutical Services Department at Rambam Medical Center, on What Role Can Equashield Robots Play in Keeping Pharmacists Safe.

Equashield's symposium will also include an augmented reality demonstration of the Equashield Pro robot. "The Equashield Pro provides the solution to hazardous drug compounding problems encountered by practicing hospital pharmacists on a daily basis," said Marino Kriheli, Co-Founder of Equashield. "By combining leading robotic automation with Equashield's proprietary CSTD technology, the Equashield Pro significantly speeds up the process of compounding hazardous drugs and creates a safer environment for oncology pharmacists around the world."

Utilizing advanced robotic technologies, the Equashield Pro enables quick compounding of a large variety of patient specific chemotherapy doses using a method that shortens the process flow while performing multiple simultaneous tasks. Comparable in size to a standard Biological Safety Cabinet, it is easily integrated into hospital pharmacies, while dose verification software protects against cases of medication dosage and identification errors.